Summary
Axon Enterprise, Inc. (AXON) reported robust revenue growth of 47.0% to $22.5 million for the first quarter of 2008, compared to $15.3 million in the same period of 2007. This growth was primarily driven by increased sales of the TASER X26 product line to law enforcement agencies, supplemented by the introduction of the TASER C2 Personal Protector product. The company also saw a significant increase in net income, rising by 146.2% to $1.2 million from $0.5 million year-over-year. Despite increased costs in Cost of Products Sold and Research & Development, the company managed to improve its operating income substantially due to strong sales leverage and a decrease in the relative proportion of SG&A expenses.
Key Highlights
- 1Net sales surged by 47.0% to $22.5 million in Q1 2008, up from $15.3 million in Q1 2007, driven by strong demand from the law enforcement market for TASER X26 and the new TASER C2.
- 2Net income more than doubled, increasing by 146.2% to $1.2 million ($0.02 per share) in Q1 2008, compared to $0.5 million ($0.01 per share) in Q1 2007.
- 3Gross margin increased by 43.6% to $12.8 million, though the gross margin percentage slightly decreased from 58.1% to 56.8% due to a shift in product mix towards lower-margin items.
- 4Research and Development expenses more than doubled, increasing by 117.4% to $2.1 million, reflecting significant investment in new product development like XREP and Shockwave.
- 5Sales, General & Administrative (SG&A) expenses grew by 20.8% to $9.2 million, but decreased as a percentage of net sales from 49.5% to 40.7%, indicating improved operational efficiency.
- 6The company maintained a strong liquidity position with $50.2 million in cash, cash equivalents, and short-term investments as of March 31, 2008.
- 7Net cash provided by operating activities turned positive at $0.7 million in Q1 2008, a significant improvement from a use of cash of $5.5 million in the prior year period.